David Sidransky - 05 Nov 2025 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Reporting relationship: Director
Issuer ticker: CSBR
Reported as of: 05 Nov 2025
Net transaction value: +$144,269
SEC form: 4
Accepted by SEC: 07 Nov 2025, 11:57:25 UTC
Prior SEC filing: 18 Nov 2024
Next SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ David Sidransky

Key filing fact

David Sidransky filed Form 4 for CHAMPIONS ONCOLOGY, INC. (CSBR) on 07 Nov 2025.

Key facts

This page summarizes David Sidransky's Form 4 filing for CHAMPIONS ONCOLOGY, INC. (CSBR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Nov 2025, 11:57.

Change

Previous filing in this sequence was filed on 18 Nov 2024.
Current net transaction value: +$144,269.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001277161 Primary reporting owner

SIDRANSKY DAVID

Relationship: Director
Address: C/O CHAMPIONS ONCOLOGY, INC., ONE UNIVERSITY PLAZA, SUITE 307, HACKENSACK
Signature: /s/ David Sidransky
Signature date: 07 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSBR transaction Derivative

Option to purchase Common Stock

Award

Transaction value: $144,269
Shares: +21,216
Change %
Price: $6.80
Shares after: 21,216
Date: 05 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,216
Exercise price: $6.80
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively.